Tech Company Financing Transactions
Enzymedica Funding Round
Enzymedica closed a venture capital round on 12/31/2013. Investors included NGEN Partners.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
771 Commerce Dr.
Venice, FL 34292
USA
Venice, FL 34292
USA
Phone
Website
Email Address
Overview
Enzymedica provides digestive enzyme supplements at the most therapeutic levels available today. Our product Digest Gold is the #1 selling enzyme in the market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Sensenbrenner
Chief Scientific Officer
Michael Murray
VP - Administration
Monica Andrichak
VP - Marketing
Ryan Sensenbrenner
VP - Sales
Paul Davison
VP - Sales
Chris Dion
VP - Sales
Yasmyn Maccaroni
Browse more venture capital transactions:
Prev: 12/31/2013: Adapteva venture capital transaction
Next: 12/31/2013: 365 Retail Markets venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs